Towards Healthcare
AI-Based Pharmaceutical R&D Services Market Forecast 2025 to 2034

AI-Based Pharmaceutical R&D Services Market Powering Future Therapies

The AI-based pharmaceutical R&D services market is growing due to rising demand for automation. North America’s dominance can be attributed to the rising R&D in developing novel therapeutics.

  • Last Updated: 13 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

AI-based pharmaceutical R&D services market, projected to reach hundreds of millions in revenue by 2034, driven by emerging trends and high industry demand.

North America is currently leading the AI-based pharmaceutical R&D services market due to rising expenditure in R&D for biologics.

Key trends include rising demand for biologics, personalized medicine, and the development of cell and gene therapies.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.